Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Messy as it can get

<< Previous

Bullboard Posts

Next >>

Comment by Trogarzonon Aug 21, 2023 5:09pm

45 Views

Post# 35598699

RE:RE:RE:RE:Messy as it can get

Hopefully we're the only ones aware of this last debacle and the good news is that we are now used to it and expecting this on a regular basis with them. We had to lowered our expectations of everything they do I guess.

<< Previous

Bullboard Posts

Next >>

Gold begins to flow at Endeavour's Lafigué mine in Côte d'Ivoire